Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017809233> ?p ?o ?g. }
- W2017809233 abstract "To combine data from all randomized trials of abciximab versus placebo or open-label control in patients with STEMI treated with primary stenting to assess the short-term and long-term mortality, reinfarction, and bleeding complications.Clinical trials of adjunctive abciximab therapy in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary stenting have produced conflicting results.Formal searches of electronic databases (Medline, Cochrane) from January 1990 to April 2009 were performed. Five trials randomizing 2,937 patients (1,475 in the abciximab group, 1,462 in the placebo group) were included in the analysis.When compared with placebo, abciximab was not associated with a significant reduction in the odds of 30-day (OR 0.71, 95% CI: 0.45-1.14, P = 0.16) or long-term (OR 0.85, 95% CI: 0.48-1.50, P = 0.57) mortality. Similarly, the rate of reinfarction was not statistically different at 30 days (OR 0.59, 95% CI: 0.30-1.17, P = 0.13) or at long-term follow-up (OR 0.67; 95% CI: 0.39-1.16, P = 0.16). However, when trials with upstream use of thienopyridines were excluded, abciximab was associated with a significant reduction in the composite of death or reinfarction at 30 days (OR 0.45; 95% CI: 0.26-0.77, P = 0.004) but not at long-term follow-up (OR 0.59; 95% CI: 0.27-1.28, P = 0.18).Routine use of abciximab in patients with STEMI treated with primary stenting may reduce short-term rates of death or reinfarction in patients not administered preprocedural thienopyridine therapy, but does not appear to be beneficial in those who receive preprocedural thienopyridines." @default.
- W2017809233 created "2016-06-24" @default.
- W2017809233 creator A5015669756 @default.
- W2017809233 creator A5015734199 @default.
- W2017809233 creator A5023500010 @default.
- W2017809233 creator A5039544037 @default.
- W2017809233 creator A5041357908 @default.
- W2017809233 creator A5046629853 @default.
- W2017809233 date "2010-01-01" @default.
- W2017809233 modified "2023-09-29" @default.
- W2017809233 title "Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting" @default.
- W2017809233 cites W1510032773 @default.
- W2017809233 cites W1983126671 @default.
- W2017809233 cites W1986626951 @default.
- W2017809233 cites W1986689269 @default.
- W2017809233 cites W2006556834 @default.
- W2017809233 cites W2020527746 @default.
- W2017809233 cites W2031944010 @default.
- W2017809233 cites W2035015235 @default.
- W2017809233 cites W2039520374 @default.
- W2017809233 cites W2054409308 @default.
- W2017809233 cites W2055474976 @default.
- W2017809233 cites W2085413583 @default.
- W2017809233 cites W2088772142 @default.
- W2017809233 cites W2089406251 @default.
- W2017809233 cites W2092944981 @default.
- W2017809233 cites W2100118923 @default.
- W2017809233 cites W2100879034 @default.
- W2017809233 cites W2122335226 @default.
- W2017809233 cites W2123875305 @default.
- W2017809233 cites W2127770458 @default.
- W2017809233 cites W2134741080 @default.
- W2017809233 cites W2152193032 @default.
- W2017809233 cites W2156927593 @default.
- W2017809233 cites W2157239643 @default.
- W2017809233 cites W2230838014 @default.
- W2017809233 cites W2314885057 @default.
- W2017809233 cites W2333133657 @default.
- W2017809233 cites W2468825798 @default.
- W2017809233 cites W2568050971 @default.
- W2017809233 doi "https://doi.org/10.1002/ccd.22349" @default.
- W2017809233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20088008" @default.
- W2017809233 hasPublicationYear "2010" @default.
- W2017809233 type Work @default.
- W2017809233 sameAs 2017809233 @default.
- W2017809233 citedByCount "9" @default.
- W2017809233 countsByYear W20178092332013 @default.
- W2017809233 countsByYear W20178092332015 @default.
- W2017809233 countsByYear W20178092332022 @default.
- W2017809233 countsByYear W20178092332023 @default.
- W2017809233 crossrefType "journal-article" @default.
- W2017809233 hasAuthorship W2017809233A5015669756 @default.
- W2017809233 hasAuthorship W2017809233A5015734199 @default.
- W2017809233 hasAuthorship W2017809233A5023500010 @default.
- W2017809233 hasAuthorship W2017809233A5039544037 @default.
- W2017809233 hasAuthorship W2017809233A5041357908 @default.
- W2017809233 hasAuthorship W2017809233A5046629853 @default.
- W2017809233 hasConcept C126322002 @default.
- W2017809233 hasConcept C142724271 @default.
- W2017809233 hasConcept C156957248 @default.
- W2017809233 hasConcept C164705383 @default.
- W2017809233 hasConcept C168563851 @default.
- W2017809233 hasConcept C203092338 @default.
- W2017809233 hasConcept C204787440 @default.
- W2017809233 hasConcept C27081682 @default.
- W2017809233 hasConcept C2777871224 @default.
- W2017809233 hasConcept C2780400711 @default.
- W2017809233 hasConcept C500558357 @default.
- W2017809233 hasConcept C71924100 @default.
- W2017809233 hasConceptScore W2017809233C126322002 @default.
- W2017809233 hasConceptScore W2017809233C142724271 @default.
- W2017809233 hasConceptScore W2017809233C156957248 @default.
- W2017809233 hasConceptScore W2017809233C164705383 @default.
- W2017809233 hasConceptScore W2017809233C168563851 @default.
- W2017809233 hasConceptScore W2017809233C203092338 @default.
- W2017809233 hasConceptScore W2017809233C204787440 @default.
- W2017809233 hasConceptScore W2017809233C27081682 @default.
- W2017809233 hasConceptScore W2017809233C2777871224 @default.
- W2017809233 hasConceptScore W2017809233C2780400711 @default.
- W2017809233 hasConceptScore W2017809233C500558357 @default.
- W2017809233 hasConceptScore W2017809233C71924100 @default.
- W2017809233 hasLocation W20178092331 @default.
- W2017809233 hasLocation W20178092332 @default.
- W2017809233 hasOpenAccess W2017809233 @default.
- W2017809233 hasPrimaryLocation W20178092331 @default.
- W2017809233 hasRelatedWork W1519563600 @default.
- W2017809233 hasRelatedWork W1540952071 @default.
- W2017809233 hasRelatedWork W1994543623 @default.
- W2017809233 hasRelatedWork W2006060848 @default.
- W2017809233 hasRelatedWork W2023233204 @default.
- W2017809233 hasRelatedWork W2023263561 @default.
- W2017809233 hasRelatedWork W2063643170 @default.
- W2017809233 hasRelatedWork W2073317979 @default.
- W2017809233 hasRelatedWork W2083079614 @default.
- W2017809233 hasRelatedWork W2083282687 @default.
- W2017809233 hasRelatedWork W2085413583 @default.
- W2017809233 hasRelatedWork W2113176985 @default.
- W2017809233 hasRelatedWork W2114864403 @default.
- W2017809233 hasRelatedWork W2128200133 @default.
- W2017809233 hasRelatedWork W2130010725 @default.